1. 1567Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48. (December 2014) Authors: Cunningham, Douglas; Shamblaw, David; Zurawski, Christine; Robbins, William; Scarsella, Anthony; Nguyen, Thai; Hindman, Jason; Ebrahimi, Ramin; Piontkowsky, David Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96‐week, phase 3b, open‐label, switch trial in virologically suppressed people ≥65 years of age. Issue 1 (8th May 2022) Authors: Maggiolo, Franco; Rizzardini, Giuliano; Molina, Jean‐Michel; Pulido, Federico; De Wit, Stephane; Vandekerckhove, Linos; Berenguer, Juan; D'Antoni, Michelle L.; Blair, Christiana; Chuck, Susan K.; Piontkowsky, David; Martin, Hal; Haubrich, Richard; McNicholl, Ian R.; Gallant, Joel Journal: HIV medicine Issue: Volume 24:Issue 1(2023) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Discontinuation of Tenofovir Disoproxil Fumarate for Presumed Renal Adverse Events in Treatment-Naïve HIV-1 Patients: Meta-analysis of Randomized Clinical Studies. Issue 6 (November 2014) Authors: Winston, Jonathan; Chonchol, Michel; Gallant, Joel; Durr, Jacques; Canada, Robert B.; Liu, Hui; Martin, Patty; Patel, Kiran; Hindman, Jason; Piontkowsky, David Journal: HIV clinical trials Issue: Volume 15:Issue 6(2014) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials. Issue 3 (4th May 2019) Authors: Kim, Yeon-Sook; Oka, Shinichi; Chetchotisakd, Ploenchan; Clarke, Amanda; Supparatpinyo, Khuanchai; Avihingsanon, Anchalee; Ratanasuwan, Winai; Kiertiburanakul, Sasisopin; Ruxrungtham, Kiat; Yang, SangYoun; Guo, Susan; Liu, YaPei; Das, Moupali; Tran, Do; McColl, Damian; Corales, Roberto; Nguyen, C... Journal: HIV research & clinical practice Issue: Volume 20:Issue 3(2019) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen. (1st August 2019) Authors: Rizzardini, Giuliano; Gori, Andrea; Miralles, Celia; Olalla, Julián; Molina, Jean-Michel; Raffi, François; Kumar, Princy; Antinori, Andrea; Ramgopal, Moti; Stellbrink, Hans-Jürgen; Das, Moupali; Chu, Hoa; Ram, Renee; Garner, Will; Shao, Yongwu; Chuck, Susan K.; Piontkowsky, David; Haubrich, Richa... Journal: AIDS Issue: Volume 33:Number 10(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Repeat testing of low-level HIV-1 RNA: assay performance and implementation in clinical trials. (15th May 2018) Authors: White, Kirsten; Garner, Will; Wei, Lilian; Eron, Joseph J.; Zhong, Lijie; Miller, Michael D.; Martin, Hal; Plummer, Andrew; Tran-Muchowski, Cecilia; Lindstrom, Kim; Porter, James; Piontkowsky, David; Light, Angela; Reiske, Heinz; Quirk, Erin Journal: AIDS Issue: Volume 32:Number 8(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study. (January 2016) Authors: van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; Arribas, José R.; Wohl, David A.; Rieger, Armin; Rachlis, Anita; Bloch, Mark; Segal-Maurer, Sorana; Garner, Will; Porter, Danielle; Bosse, Matthew; Piontkowsky, David; Chuck, Susan K.; De-Oertel, Shampa Journal: AIDS Issue: Volume 30:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Selected CNS Outcomes Among INSTI Antiretrovirals. (4th October 2017) Authors: Wohl, David; Mills, Anthony; Mera, Robertino; Piontkowsky, David Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI. Issue 4 (4th July 2017) Authors: Pozniak, Anton; Flamm, Jason; Antinori, Andrea; Bloch, Mark; Ward, Douglas; Berenguer, Juan; Cote, Pierre; Andreatta, Kristen; Garner, William; Szwarcberg, Javier; Nguyen-Cleary, Thai; McColl, Damian J.; Piontkowsky, David Journal: HIV clinical trials Issue: Volume 18:Issue 4(2017) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Virological Outcomes of EVG/COBI/FTC/TDF and EVG/COBI/FTC/TAF in Antiretroviral-Naive HIV-1-Infected Participants with Baseline HIV-1 RNA ≥1, 000, 000 Copies/ml: A Post Hoc Analysis of Phase III Clinical Trials. Issue 1 (January 2018) Authors: Sax, Paul; DeJesus, Edwin; Wohl, David; DeMorin, Jennifer; McColl, Damian; Piontkowsky, David; Cohen, Calvin; Wang, Hui; White, Kirsten; Callebaut, Christian; Rhee, Martin; Das, Moupali; Quirk, Erin Journal: Antiviral therapy Issue: Volume 23:Issue 1(2018) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗